Long term follow up of peripheral lymphocyte subsets in a cohort of multiple sclerosis patients treated with natalizumab. Koudriavtseva T, Sbardella E, Trento E, Bordignon V, D'Agosto G, Cordiali-Fei P Clin Exp Immunol. 2014 Jan 6. PMID: 24387139. Abstract CommentRecommendBookmarkWatch